CMAJ expands advisory oversight across medicine, patients, and practice
_CMAJ_ has published its advisory panels, laying out a governance structure that brings together scholars in medicine and society, patient representatives, and clinicians with practice experience. The roster is not a clinical trial and does not generate efficacy data, but it does show how the journal organizes expertise around editorial judgment, patient perspective, and real-world care delivery.
The three panels sit in distinct but overlapping domains. The Medicine and Society Advisory Panel includes Stephen Casper, Jacalyn Duffin, Andrew J. Hogan, Susan Lamb, Darryl Manitowabi, Judy Z. Segal, and Jaipreet Virdi. Their affiliations span Clarkson University, Queen’s University, Creighton University, the University of Ottawa, the Northern Ontario School of Medicine University, and the University of British Columbia, along with institutions in the United States. That mix signals a strong emphasis on medical humanities, history, communication, and social context rather than narrow subspecialty consultation.
The composition matters because journal decisions do not happen in a vacuum. Editorial choices in medicine increasingly intersect with questions about disability, colonial history, communication ethics, public trust, and the social conditions that shape health. A panel built around those issues can help a medical journal examine whether language, framing, and publication priorities reflect the patients and communities they affect.
Patient representation is built into the journal structure
The Patient Advisory Panel lists Majd Al-Aarg, Sharla Adams, Gerald Crowell, Amanda Doherty-Kirby, Joelle Fawcett-Arsenault, Fiona Fu, Christina Gilman, Alex Haagaard, Louis Lochhead, Sharon Roman, Linda Wilhelm, and Tabassum Wyne. Several names are linked to provincial affiliations, including Ontario, Québec, and British Columbia, showing a geographically distributed group of patient contributors.
A patient panel changes the editorial conversation in a concrete way. It can bring forward questions clinicians and researchers may miss: how terminology lands outside academic medicine, whether a manuscript’s framing captures lived experience, and whether a proposed policy is likely to resonate with the people who must navigate it. In practice, patient advisory input is often most useful when it is allowed to challenge professional assumptions rather than simply validate them.
One plain fact stands out. Patient participation is not symbolic when a journal publishes the names of its advisers alongside formal competing interests disclosures. The structure suggests that patient expertise is being treated as a stable part of the journal’s editorial process, not as an occasional consultation.
Practice voices reflect frontline medicine and system pressures
The Practice Advisory Panel includes Sarah-Taïssir Bencharif, Adrian Budhram, Donna May Kimmaliardjuk, Aisha Lofters, Ray Markham, Rupa Patel, and Geoffrey Reaume. Their roles span locum work in Ottawa and northern Ontario, neurology, cardiac surgery, equity-focused primary care, rural general practice in Valemount, family medicine in Kingston, and health policy or academic work in Toronto and elsewhere.
This mix brings the realities of clinical work into a journal environment that otherwise risks being dominated by academic settings. Rural practice, locum coverage, and equity-oriented care expose different fault lines than tertiary referral medicine. Access barriers, continuity gaps, workforce shortages, and culturally safe care are routine concerns in those settings, and advisory input from clinicians who work there can sharpen how a journal interprets health-system evidence.
The diversity of titles and locations also suggests a deliberate attempt to avoid a single-center or single-discipline perspective. A journal advisory panel shaped by rural clinicians, academic physicians, and specialists can better interrogate whether evidence will translate outside major urban hospitals. That is especially relevant for primary care, where implementation often depends on staffing, geography, and local patient need rather than on trial data alone.
Editorial governance leans on disclosed affiliations and competing interests
Each panelist is paired with a competing interests disclosure link. In a journal setting, that administrative detail is more than paperwork. It indicates that _CMAJ_ is organizing advisory participation within a disclosure framework designed to make professional relationships visible before they influence editorial decisions.
Transparency of this kind does not eliminate bias, but it makes oversight more traceable. When a medical journal publishes advisory memberships and conflict disclosures, readers can see which kinds of expertise are informing the publication’s internal standards. Medical publishing has long been criticized when editorial direction appears opaque. Publicly named advisory panels push in the opposite direction, toward visible accountability.
The list also reflects how modern medical publishing extends beyond the traditional circle of physicians and researchers. Historians, humanists, patients, rural practitioners, and equity-oriented clinicians are all represented. In editorial terms, that broadens the kinds of questions a journal can ask before a manuscript becomes part of the medical record.
There is no trial endpoint here, no intervention arm, and no comparative effect estimate. The value lies in governance. Advisory panels like these shape how medical knowledge is filtered, framed, and shared, and the names on the page show _CMAJ_ relying on a deliberately mixed panel of voices to do that work.
The remaining question is not whether advisory structures exist, but how visibly they continue to influence published priorities, language, and editorial standards as medicine keeps confronting inequity, access problems, and public skepticism about expertise.